Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Baruffini

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Mitochondrion|December 3, 2014
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiaeEnrico Baruffini, Jessica Ferrari, Cristina Dallabona, et al.
Plant Physiology and Biochemistry : PPB|September 3, 2014
Glutamate dehydrogenase isoenzyme 3 (GDH3) of Arabidopsis thaliana is less thermostable than GDH1 and GDH2 isoenzymesLaura Marchi, Eugenia Polverini, Francesca Degola, et al.
Human Molecular Genetics|August 31, 2006
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humansEnrico Baruffini, Tiziana Lodi, Cristina Dallabona, et al.
Frontiers in Genetics|April 9, 2015
DNA polymerase γ and disease: what we have learned from yeastTiziana Lodi, Cristina Dallabona, Cecilia Nolli, et al.
International Journal of Molecular Sciences|July 14, 2023
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast <i>Saccharomyces cerevisiae</i>Martina Magistrati, Alexandru Ionut Gilea, Maria Carla Gerra, et al.
Human Molecular Genetics|December 23, 2015
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseasesLaras Pitayu, Enrico Baruffini, Celine Rodier, et al.
International Journal of Molecular Sciences|February 11, 2023
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease ModelsMartina Magistrati, Alexandru Ionut Gilea, Camilla Ceccatelli Berti, et al.
Scientific Reports|March 21, 2026
Progressive cognitive impairment and ventricular tachycardia in a boy with biallelic POLG variants and a de novo RYR2 variationValentina Fumini, Alexandru Ionut Gilea, Elena Tacchetto, et al.
International Journal of Molecular Sciences|April 30, 2021
Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast Contribution for Functional Analysis of Novel VariantsSonia Figuccia, Andrea Degiorgi, Camilla Ceccatelli Berti, et al.
International Journal of Molecular Sciences|November 27, 2021
A Yeast-Based Repurposing Approach for the Treatment of Mitochondrial DNA Depletion Syndromes Led to the Identification of Molecules Able to Modulate the dNTP PoolGiulia di Punzio, Micol Gilberti, Enrico Baruffini, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Mitochondrion|December 3, 2014
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiaeEnrico Baruffini, Jessica Ferrari, Cristina Dallabona, et al.
Plant Physiology and Biochemistry : PPB|September 3, 2014
Glutamate dehydrogenase isoenzyme 3 (GDH3) of Arabidopsis thaliana is less thermostable than GDH1 and GDH2 isoenzymesLaura Marchi, Eugenia Polverini, Francesca Degola, et al.
Human Molecular Genetics|August 31, 2006
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humansEnrico Baruffini, Tiziana Lodi, Cristina Dallabona, et al.
Frontiers in Genetics|April 9, 2015
DNA polymerase γ and disease: what we have learned from yeastTiziana Lodi, Cristina Dallabona, Cecilia Nolli, et al.
International Journal of Molecular Sciences|July 14, 2023
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast <i>Saccharomyces cerevisiae</i>Martina Magistrati, Alexandru Ionut Gilea, Maria Carla Gerra, et al.
Human Molecular Genetics|December 23, 2015
Combined use of Saccharomyces cerevisiae, Caenorhabditis elegans and patient fibroblasts leads to the identification of clofilium tosylate as a potential therapeutic chemical against POLG-related diseasesLaras Pitayu, Enrico Baruffini, Celine Rodier, et al.
International Journal of Molecular Sciences|February 11, 2023
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease ModelsMartina Magistrati, Alexandru Ionut Gilea, Camilla Ceccatelli Berti, et al.
Scientific Reports|March 21, 2026
Progressive cognitive impairment and ventricular tachycardia in a boy with biallelic POLG variants and a de novo RYR2 variationValentina Fumini, Alexandru Ionut Gilea, Elena Tacchetto, et al.
International Journal of Molecular Sciences|April 30, 2021
Mitochondrial Aminoacyl-tRNA Synthetase and Disease: The Yeast Contribution for Functional Analysis of Novel VariantsSonia Figuccia, Andrea Degiorgi, Camilla Ceccatelli Berti, et al.
International Journal of Molecular Sciences|November 27, 2021
A Yeast-Based Repurposing Approach for the Treatment of Mitochondrial DNA Depletion Syndromes Led to the Identification of Molecules Able to Modulate the dNTP PoolGiulia di Punzio, Micol Gilberti, Enrico Baruffini, et al.
Pageof 6